FindTrial
Sign In

Comparing efficacy of Medication versus Yoga in Chronic Pelvic Pain Syndrome in males

Comparing efficacy of Alfuzosin and Amitriptyline versus Yoga and Placebo in Males with Chronic Pelvic Pain Syndrome: A Single-Center Randomized Crossover Trial - CPPS trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042706
Enrollment
40
Registered
2022-05-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R398- Other symptoms and signs involvingthe genitourinary system

Interventions

Intervention1: Alfuzosin and amitriptyline : Dosages of drug- Amitriptyline (10mg-100mg) per day, Alfuzosin (10 mg) once daily, for 6 weeks Control Intervention1: Placebo and Yoga: Placebo and Yoga fo

Sponsors

AIIMS bhubaneswar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Those who meet the CP / CPPS western medical diagnostic criteria b) Those whose disease course exceeds 3 months QOL score 3 or greater. c) 20-50 years old; d) Those who have signed informed consent.

Exclusion criteria

Exclusion criteria: a) Patients refusing consent b) Patient with a history of pelvic surgery c) Persons with abnormal development or infection of urogenital system d) Prostate tuberculosis, benign prostatic hyperplasia and prostate cancer, acute urethral syndrome; e) Patients with severe physical illness, systemic failure, and allergies to Alfuzosin hydrochloride sustained-release capsule drugs

Design outcomes

Primary

MeasureTime frame
reduction in NIH-CPSI scoreTimepoint: At base line, at 3 weeks and at 6 weeks—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactAbhay Singh

AIIMs Bhubaneswar

drabhaygaur@live.com6372736597

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 31, 2026